Imerys (NK) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Oct, 2026Executive summary
9M 2026 revenue reached €2.624bn, up 2.0% like-for-like; adjusted EBITDA rose 10.3% to €450m, with margin expanding 0.8pp to 17.1%.
Q3 revenue increased 2.9% like-for-like to €884m; adjusted EBITDA grew 10.8% to €160m, lifting margin 1.2pp to 18.1%.
FY 2026 adjusted EBITDA guidance rose to €570m–€590m from €550m–€580m, assuming no material deterioration in operating conditions.
Financial highlights
9M volumes increased 0.4% and prices 1.6%; Q3 sales rose 7.0% reported and 2.9% like-for-like.
9M current operating income was €225m, up 10.3% like-for-like; reported operating income was €199m, up 0.8%.
9M net income, Group share, was €92m, down 16.3% reported; current net income was €116m versus €126m.
Q3 net income, Group share, was €43m, up 8.0%; current net income, Group share, rose 16.9% to €50m.
Outlook and guidance
FY 2026 adjusted EBITDA guidance increased to €570m–€590m from €550m–€580m; FY results were expected to be significantly above 2025.
Guidance assumes no material deterioration in operating conditions; inflationary pressures and challenging markets are expected to persist near term.
Priorities include disciplined pricing, margin protection, cost optimization, cash generation, financial discipline and strategic growth initiatives.
Project Horizon’s full-year savings target remained €50m–€60m; €30m had been delivered through Q3, ahead of schedule.
Latest events from Imerys
- H1 2026 saw 1.8% revenue and 10% EBITDA growth, margin gains, and strong cash flow.NK
Q2 2026 - Stable results, €0.75 dividend, strategic focus on lithium, cost savings, and strong ESG progress.NK
AGM 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 2025 - Nine-month revenue fell 0.7% to €2,583m; EBITDA guidance and cost actions reaffirmed.NK
Q3 2025 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 2024 - H1 2024 adjusted EBITDA up 11% to €384m, margin 20%, and net income from continuing ops up 25%.NK
H1 2024 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 2025 - Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 2024